This brand name is authorized in Austria, Canada, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Italy, Japan, Lithuania, Poland, Romania, Turkey, United Kingdom, United States
The drug SAMSCA contains one active pharmaceutical ingredient (API):
1
Tolvaptan
UNII 21G72T1950 - TOLVAPTAN
|
Tolvaptan is a selective vasopressin V2-receptor antagonist that specifically blocks the binding of arginine vasopressin (AVP) at the V2-receptor of the distal portions of the nephron. Tolvaptan affinity for the human V2-receptor is 1.8 times that of native AVP. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
SAMSCA Tablet | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
C03XA01 | Tolvaptan | C Cardiovascular system → C03 Diuretics → C03X Other diuretics → C03XA Vasopressin antagonists |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: CA | Health Products and Food Branch | Identifier(s): 02370468, 02370476 |
Country: EE | Ravimiamet | Identifier(s): 1433933, 1433944, 1433955, 1433966, 1753624, 1753635, 1847392, 1847404 |
Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 09539001, 09539003, 109539007 |
Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 038376, 038399, 165319, 553802 |
Country: FR | Base de données publique des médicaments | Identifier(s): 63371428, 63790853, 67412139 |
Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 159346, 159352, 367567 |
Country: HK | Department of Health Drug Office | Identifier(s): 59910, 59911 |
Country: IT | Agenzia del Farmaco | Identifier(s): 039551015, 039551027, 039551039, 039551041, 039551054, 039551066, 039551078, 039551080 |
Country: JP | 医薬品医療機器総合機構 | Identifier(s): 2139011D1022, 2139011F3026, 2139011F4022, 2499012F2029 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1050734, 1050735, 1050736, 1050737, 1084008, 1084009, 1086390, 1086391 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100316415, 100316421, 100417553 |
Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W67142001, W67142002, W67143001, W67143002 |
Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8680683010019, 8680683010026, 8680683010033, 8680683010040 |
Country: US | FDA, National Drug Code | Identifier(s): 59148-020, 59148-021 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.